Codexis (CDXS) Free Cash Flow (2010 - 2026)
Codexis (CDXS) recorded quarterly Free Cash Flow of -$13.3 million in Q1 2026, down 155.5% quarter-over-quarter from $24.0 million in Q4 2025, and up 16.04% on a YoY basis from -$11.5 million in Q1 2025.
Codexis (CDXS) Free Cash Flow (2010 - 2026) Analysis & Trends
Codexis' Free Cash Flow history runs 17 years deep, the most recent figure standing at -$13.3 million for Q1 2026.
- In Q1 2026, Free Cash Flow rose 16.04% year-over-year to -$13.3 million; the TTM figure through Mar 2026 stood at -$16.9 million (up 72.55% YoY), while the FY2025 annual figure was -$19.4 million, up 63.87% from the prior year.
- Free Cash Flow was -$13.3 million for Q1 2026 at Codexis, down from $24.0 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $26.6 million in Q3 2022 to a low of -$20.7 million in Q3 2023.
- Historically, Free Cash Flow has averaged -$8.1 million across 5 years, with a median of -$12.6 million in 2024.
- Biggest YoY gain for Free Cash Flow was 1144.67% in 2022; the steepest drop was 2446.76% in 2022.
- A 5-year view of Free Cash Flow shows it stood at -$3.3 million in 2022, then sank by 124.0% to -$7.3 million in 2023, then sank by 149.65% to -$18.2 million in 2024, then jumped by 231.63% to $24.0 million in 2025, then slumped by 155.5% to -$13.3 million in 2026.
- The last three Free Cash Flow figures came in at -$13.3 million (Q1 2026), $24.0 million (Q4 2025), and -$11.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 63,220.27 |
| 10 | Codexis | 226.01 Mn | 160.87 Mn | 13.18 Mn | -13.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.33 Mn |
| Mar 31, 2026 | -13.33 Mn |
| Dec 31, 2025 | 24.01 Mn |
| Dec 31, 2025 | 24.01 Mn |
| Sep 30, 2025 | -11.61 Mn |
| Sep 30, 2025 | -11.61 Mn |
| Jun 30, 2025 | -15.94 Mn |
| Jun 30, 2025 | -15.94 Mn |
| Mar 31, 2025 | -15.87 Mn |
| Mar 31, 2025 | -15.87 Mn |
| Dec 31, 2024 | -18.24 Mn |
| Dec 31, 2024 | -18.24 Mn |
| Sep 30, 2024 | -14.75 Mn |
| Sep 30, 2024 | -14.75 Mn |
| Jun 30, 2024 | -12.57 Mn |
| Jun 30, 2024 | -12.57 Mn |
| Mar 31, 2024 | -8.16 Mn |
| Mar 31, 2024 | -8.16 Mn |
| Dec 31, 2023 | -7.31 Mn |
| Dec 31, 2023 | -7.31 Mn |